Please visit our MS learning channel on Youtube, which provides hundreds of topics from our education programs, that were video-recorded and archived here: www.youtube.com/msviewsandnews -- Be empowered with MS news by registering with us: www.register.msviewsandnews.org

joomla ecommerce template -- Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

============================================================

Saturday, April 14, 2012

MS Dream Center of Rhode Island - Helps People with MS


The mission of the MS Dream Center is to engage all members with Multiple Sclerosis in purposeful activity, while promoting a spirit of camaraderie. Activities at the Center include a support group, seminars delivered by leading medical professionals, a variety of exercise and art programs, as well as various complimentary therapies like reflexology and massage. Importantly, it is a place where people with MS, their caregivers, and their loved ones can come to share in fellowship.

Click here to watch a Video About the MS DREAM Center 

People with MS, Helping People with MS



..
Comments are appreciated. Note that All comments are moderated 
 If not yet receiving our weekly e-Newsletter Click here to: REGISTER -
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

..............................

Friday, April 13, 2012

Bridge the Gap Between Basic Research and Patient Care, NIH Head Urges


Information provided by Mitchell A., in California




Associated Press
Francis Collins, head of the National Institutes of Health, painted a stark picture at TEDMED about the difficulty of translating basic scientific knowledge into applications that could be useful to patients.
We need to “build a bridge across this yawning gap,” Collins told the audience at this gathering in Washington of researchers and other thinkers to discuss the future of health care. Collins first serenaded the crowd with his guitar and a song about the need to knock out disease.
Imagining the gulf between basic science and applications as a body of water, Collins said linking them wouldn’t be like building the Golden Gate Bridge.
Click here to read more





..
Comments are appreciated. Note that All comments are moderated 
 If not yet receiving our weekly e-Newsletter Click here to: REGISTER -
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

..............................

Patient on Novartis' multiple sclerosis drug gets rare brain disease - PML...



Published April 13, 2012
The Wall Street Journal


Novartis said Friday a patient treated with its multiple sclerosis (MS) pill Gilenya was diagnosed with a rare and often fatal brain disease.

The Swiss drugmaker said the patient, whose identity was not disclosed, previously was treated with another MS drug, Tysabri, co-marketed by Biogen Idec and Elan, which already was associated with progressive multifocal leukoencephalopathy (PML).

"The current assessment is that Tysabri is the drug most likely associated with this case of PML," Novartis said. "However, a contribution of Gilenya to the evolution of this case can't be excluded."

The development comes at a critical time for Novartis' Gilenya, whose safety profile recently came into question after the death of one person in the US last fall within 24 hours of starting treatment. Heart problems in some patients also were reported.

The European Medicines Agency, the body responsible for licensing Gilenya in Europe a year ago, is expected to issue a decision on the safety of the medicine April 20 following an in-depth review.


Read more: http://www.foxnews.com/health/2012/04/13/patient-on-novartis-multiple-sclerosis-drug-gets-rare-brain-disease/#ixzz1rwTA91Br
 




..
Comments are appreciated. Note that All comments are moderated 
 If not yet receiving our weekly e-Newsletter Click here to: REGISTER -
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

..............................

Univ of Rochester neurologist scores national MS fellowship





Jessica Robb, after nearly four years of a neurology residency at Strong Memorial Hospital, is going nowhere soon.
The National Multiple Sclerosis Society has a hand in that, which is more than OK with Robb.
Robb has a $65,000 grant from the National Multiple Sclerosis Society to pay for a year of high-level training in multiple sclerosis care, which she will take right at Strong’s main neurology clinic.
Robb is one of only seven physicians in the nation to receive the Multiple Sclerosis Clinical Care Physician Fellowship this year.









..
Comments are appreciated. Note that All comments are moderated 
 If not yet receiving our weekly e-Newsletter Click here to: REGISTER -
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

..............................

Thursday, April 12, 2012

The "CAN DO" Webinar Series includes Adaptive techniques, Cooling and Traveling with MS


I AM. I CAN. I WILL.




I AM. I CAN. I WILL.
I AM. I CAN. I WILL.

I AM. I CAN. I WILL.
I AM. I CAN. I WILL.
I AM. I CAN. I WILL.


============================
..
Comments are appreciated. Note that All comments are moderated 
 If not yet receiving our weekly e-Newsletter Click here to: REGISTER -
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

..............................

Wednesday, April 11, 2012

Ocular Migraine Symptoms and Diagnosis


LIFE IS NOT ONLY ABOUT MS and So, this next article is NOT MS RELATED


Symptoms of Ocular Migraines

In 50% of cases, ocular migraines cause temporary but complete vision loss in one eye. In the other half of cases, ocular migraines can cause vision disturbances such as:
  • Blurring
  • Partial vision loss
  • Scotomas, or a blank spots in your vision
  • Dimming
  • Flashes of light
Ocular migraines are usually brief, lasting less than five minutes. However, they can last up to 30 minutes. Forty-one percent of people have a headache during the vision loss. Twenty-five percent have it before or after.


Diagnosing Ocular Migraines

If you get to the doctor during an ocular migraine, he or she will be able to see the decreased blood flow in your eye with a device called a fundoscope. However, since ocular migraines are fairly brief, it's more likely that you will be diagnosed based on your symptoms.
The symptoms of ocular migraines are similar to those of other serious disorders, such as eye diseases and stroke. So your doctor will want to do a thorough evaluation. If you have any of the risk factors below, your doctor may run additional tests to rule out more serious conditions:
  • Have no history of migraines
  • Are older than age 50
  • Have cardiovascular disease


Further Reading:


SOURCE: WEBMD



..
Comments are appreciated. Note that All comments are moderated 
 If not yet receiving our weekly e-Newsletter Click here to: REGISTER -
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

..............................

Intrepid Investors Eye Use Of Pig Whipworm Eggs To Quell Crohn's Disease and MS


YUK - was Stu's first reaction
~~~~~~~~~~~~~~~~~~~~
Dr. Lindsay Rosenwald is a familiar name onWall Street, a long-time investor with 23 years of experience as a biotechnology entrepreneur, instrumental in founding and recapitalizing a large number of public and private life sciences companies, including Cougar Biotechnology which was acquired by Johnson & Johnson for $1 billion in 2009.
The latest company he has formed is again catching the eye of biotech investors: Coronado Biosciences (CNDO), which is developing two therapies that alter the activity of the immune system. Its probiotic treatment consists of “Trichuris suis ova (TSO),” or non-infectious porcine whipworm eggs, to quell inflammation and abnormal immune function that causes such autoimmune diseases as multiple sclerosis (MS), inflammatory bowel disease, and type 1 diabetes.
“The lead indication is Crohn’s Disease, though MS is not far behind,” says Dr. Keith A. Markey, life sciences analyst at investment firm Griffin Securities. Its second program, he notes, relies on a proprietary method to activate natural killer cells of the innate immune system to combat cancer. Those killer cells, which have shown promise against solid and hematological malignancies, are being developed to treat acute myeloid leukemia, says the analyst.
“Coronado has a proprietary method of activating the killer cells ‘ex vivo’ to create a personalized medicine for a variety of malignancies, says Dr. Markey. Coronado is collaborating with European companies on the probiotic project and will likely seek other foreign companies to market its natural killer-cells therapy, he adds.


Comments are appreciated. Note that All comments are moderated 
 If not yet receiving our weekly e-Newsletter Click here to: REGISTER -
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

..............................